Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $8.14 billion. The enterprise value is $7.31 billion.
| Market Cap | 8.14B |
| Enterprise Value | 7.31B |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 65.27 million shares outstanding. The number of shares has increased by 8.19% in one year.
| Current Share Class | 65.27M |
| Shares Outstanding | 65.27M |
| Shares Change (YoY) | +8.19% |
| Shares Change (QoQ) | +1.02% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 106.67% |
| Float | 53.36M |
Valuation Ratios
The trailing PE ratio is 25.30 and the forward PE ratio is 56.20.
| PE Ratio | 25.30 |
| Forward PE | 56.20 |
| PS Ratio | 14.75 |
| Forward PS | 32.75 |
| PB Ratio | 7.49 |
| P/TBV Ratio | 7.50 |
| P/FCF Ratio | 74.55 |
| P/OCF Ratio | 74.03 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.52, with an EV/FCF ratio of 66.98.
| EV / Earnings | 21.36 |
| EV / Sales | 13.25 |
| EV / EBITDA | 22.52 |
| EV / EBIT | 22.63 |
| EV / FCF | 66.98 |
Financial Position
The company has a current ratio of 19.85, with a Debt / Equity ratio of 0.01.
| Current Ratio | 19.85 |
| Quick Ratio | 19.76 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.08 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 39.56% and return on invested capital (ROIC) is 174.60%.
| Return on Equity (ROE) | 39.56% |
| Return on Assets (ROA) | 21.85% |
| Return on Invested Capital (ROIC) | 174.60% |
| Return on Capital Employed (ROCE) | 29.61% |
| Weighted Average Cost of Capital (WACC) | 10.93% |
| Revenue Per Employee | $3.70M |
| Profits Per Employee | $2.30M |
| Employee Count | 149 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $7.99 million in taxes.
| Income Tax | 7.99M |
| Effective Tax Rate | 2.28% |
Stock Price Statistics
The stock price has increased by +47.35% in the last 52 weeks. The beta is 1.22, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | +47.35% |
| 50-Day Moving Average | 139.46 |
| 200-Day Moving Average | 119.71 |
| Relative Strength Index (RSI) | 32.47 |
| Average Volume (20 Days) | 593,761 |
Short Selling Information
The latest short interest is 10.24 million, so 15.69% of the outstanding shares have been sold short.
| Short Interest | 10.24M |
| Short Previous Month | 10.30M |
| Short % of Shares Out | 15.69% |
| Short % of Float | 19.19% |
| Short Ratio (days to cover) | 13.75 |
Income Statement
In the last 12 months, PTGX had revenue of $551.69 million and earned $342.26 million in profits. Earnings per share was $4.93.
| Revenue | 551.69M |
| Gross Profit | 550.59M |
| Operating Income | 323.10M |
| Pretax Income | 350.25M |
| Net Income | 342.26M |
| EBITDA | 324.68M |
| EBIT | 323.10M |
| Earnings Per Share (EPS) | $4.93 |
Balance Sheet
The company has $834.62 million in cash and investments and $8.63 million in debt, with a net cash position of $825.99 million or $12.65 per share.
| Cash & Investments | 834.62M |
| Total Debt | 8.63M |
| Net Cash | 825.99M |
| Net Cash Per Share | $12.65 |
| Equity (Book Value) | 1.08B |
| Book Value Per Share | 16.64 |
| Working Capital | 1.05B |
Cash Flow
In the last 12 months, operating cash flow was $109.91 million and capital expenditures -$764,000, giving a free cash flow of $109.15 million.
| Operating Cash Flow | 109.91M |
| Capital Expenditures | -764,000 |
| Depreciation & Amortization | 1.59M |
| Net Borrowing | n/a |
| Free Cash Flow | 109.15M |
| FCF Per Share | $1.67 |
Margins
Gross margin is 99.80%, with operating and profit margins of 58.56% and 62.04%.
| Gross Margin | 99.80% |
| Operating Margin | 58.56% |
| Pretax Margin | 63.49% |
| Profit Margin | 62.04% |
| EBITDA Margin | 58.85% |
| EBIT Margin | 58.56% |
| FCF Margin | 19.78% |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.19% |
| Shareholder Yield | -8.19% |
| Earnings Yield | 3.95% |
| FCF Yield | 1.34% |
Analyst Forecast
The average price target for PTGX is $182.36, which is 46.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $182.36 |
| Price Target Difference | 46.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 108.20% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 67.25 and a Piotroski F-Score of 5.
| Altman Z-Score | 67.25 |
| Piotroski F-Score | 5 |